Skip to main content

Table 1 Distributions of baseline variables by colonic diverticulitis group

From: Utility of monocyte distribution width in the differential diagnosis between simple and complicated diverticulitis: a retrospective cohort study

Variables

Total

Simple Diverticulitis

Complicated Diverticulitis

p-value

Patients, n (%)

160 (100)

139 (86.875)

21 (13.125)

 

Female sex, n (%)

70 (43.75)

62 (44.604)

8 (38.095)

0.642

Age in years, median (IQR)

45 (31.25–60)

44 (30–59)

58 (41–72)

0.008*

Body mass index

23.821 (20.701–26.892)

23.875 (20.700–26.892)

23.624 (20.695–26.388)

0.950

Body Temperature (℃), median (IQR)

36.8 (36.5–37.375)

36.8 (36.5–37.3)

37.2 (36.45–37.5)

0.273

Recurrent diverticulitis, n (%)

27 (16.875)

21 (15.108)

6 (28.571)

0.129

Multiple locations of diverticula, n (%)

17 (10.625)

15 (10.791)

2 (9.524)

1.000

Location of diverticulitis, n (%)

0.001*

 Right colon:

112 (70)

104 (74.820)

8 (38.095)

 

     Cecum

14 (8.750)

14 (10.072)

0 (0)

 

     Ascending colon

91 (56.875)

85 (61.151)

6 (28.571)

 

     Transverse colon

7 (4.375)

5 (3.597)

2 (9.524)

 

 Left colon:

48 (30)

35 (25.180)

13 (61.905)

 

     Descending colon

24 (15)

19 (13.669)

5 (23.810)

 

     Sigmoid colon

24 (15)

16 (11.511)

8 (38.095)

 

Comorbidities, n (%)

 Diabetes mellitus

10 (6.25)

9 (6.475)

1 (4.762)

1.000

 Hypertension

30 (18.75)

25 (17.986)

5 (23.810)

0.551

 Ischemic heart disease

8 (5)

7 (5.036)

1 (4.762)

1.000

 Heart failure

2 (1.25)

2 (1.439)

0 (0)

1.000

 Liver cirrhosis

1 (0.625)

1 (0.719)

0 (0)

1.000

 Cholelithiasis

10 (6.25)

9 (6.475)

1 (4.762)

1.000

 Rheumatologic disease

2 (1.25)

1 (0.719)

1 (4.762)

0.246

 Asthma / COPD

2 (1.25)

1 (0.719)

1 (4.762)

0.246

 Chronic renal insufficiency

4 (2.5)

3 (2.158)

1 (4.762)

0.434

 Urolithiasis

10 (6.25)

7 (5.036)

3 (14.286)

0.127

 Cerebrovascular disease

1 (0.625)

1 (0.719)

0 (0)

1.000

 Existing cancer

4 (2.5)

4 (2.878)

0 (0)

1.000

Laboratory Data, median (IQR)

 WBC × 10^9 /L

11.15 (8.7–13.775)

10.9 (8.6–13.6)

13.3 (11.0–15.45)

0.008*

 Neutrophils (%)

76.75 (69.825–82)

75.2 (68.8–81.4)

80.1 (76.8–86.3)

0.003*

 Lymphocytes (%)

14.2 (9.7–20.05)

14.9 (10.5–20.9)

9.5 (5.9–14.25)

0.001*

 MDW

18.78 (17.44–20.6475)

18.56 (17.21–19.77)

22.66 (20.655–24.465)

< 0.001*

 Platelets × 10^9 /L

243 (196–286)

244 (197–286)

227 (188.5–310)

0.893

 NLR

5.357 (3.478–8.363)

5.040 (3.305–7.524)

8.372 (5.431–15.057)

0.001*

 PLR

152.383 (121.295–207.622)

148.457 (120.351–196.479)

206.860 (141.476–366.163)

0.017*

 CRP (mg/dL)

3.835 (0.9675–9.06)

3.46 (0.67–6.08)

12.14 (5.235–15.42)

< 0.001*

 Alanine aminotransferase (U/L)

18.5 (12–26.75)

18 (12–26)

19 (12–34.5)

0.750

 Creatinine (mg/dL)

0.8 (0.6525–0.9575)

0.79 (0.66–0.95)

0.86 (0.61–1.135)

0.471

 Sodium (mmol/L)

139 (137–140)

139 (138–140)

137 (136–138)

< 0.001*

 Potassium (mmol/L)

3.7 (3.5–3.9)

3.7 (3.6–3.9)

3.7 (3.4–3.9)

0.251

 Glucose (mg/dL)

104.5 (94–123)

105 (94–123)

103 (92–135)

0.860

  1. IQR Interquartile range, COPD Chronic obstructive pulmonary disease, WBC White blood count, MDW Monocyte distribution width, NLR Neutrophil to lymphocyte ratio, PLR Platelet to lymphocyte ratio, CRP C-reactive protein, ALT Alanine aminotransferase
  2. * P < 0.05